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Adipose tissue
�� t�e last 20 years, t�e p�ys��al, me��
tal a�d e�o�om�� ��rde� of o�es�
�ty a�d related d�seases �s rea����� 
pa�dem�� proport�o�s. Ar��a�ly, �e 
�ave lear�ed more a�o�t t�e mole���
lar �o�trol of food ��take a�d e�er�y 
�omeostas�s. �t �s a� ��tr��ate feed�a�k 
system �� ����� food ��take a�d e�er�
�y expe�d�t�re are �ala��ed t�ro��� 
�ra���ad�pose, �ra�����t, e�tero���s��
lar a�d re�ard ��r���ts. 
 W��te a�d �ro�� ad�pose t�ss�e 
(WAT a�d BAT) are morp�olo���
�al a�d f���t�o�al express�o�s of a 
dy�am�� system, �o�s�st��� of ad��
po�ytes a�d �o��ad�po�yte �ell�lar 
eleme�ts, ���l�d��� stromal, vas��lar, 
�erve a�d �mm��e �ells (1). Ad�pose 
t�ss�e (“WAT” ��ll �e ass�med from 
�ereo�) also �o�ta��s �ells t�at �ave 
t�e a��l�ty to d�ffere�t�ate ��to several 
l��ea�es ���l�d��� �e�ro�al �ells. By 
se�d��� a�d re�e�v��� d�ffere�t types 
of prote�� a�d �o��prote�� s���als, 
ad�pose t�ss�e �omm����ates v�a 
Abstract
Adipose tissue is a sophisticated module, consisting of adipocytes and non-adipocyte 
cellular elements including stromal, vascular, nerve and immune cells. There is at 
present evidence that sharing of ligands and their receptors constitutes a molecular 
language of the human’s body, which is also the case for adipose tissue and hypo-
thalamus-pituitary gland. Historically, Nikolai Kulchitsky’s identification of the entero-
chromaffin cell in 1897 formed the basis for the subsequent delineation of the diffuse 
neuroendocrine system (DNES) by Friedrich Feyrter in 1938. In DNES paradigm, the 
secretion of hormones, neuropeptides and neurotrophic factors is executed by cells 
disseminated throughout the body, for example, Kulchitsky (enterochromaffin) cells, 
testicular Leydig cells, and hepatic stellate cells. Here we propose that the adipose tis-
sue might be a new member of DNES. Today (dnes, in Bulgarian), adipose tissue is “get-
ting nervous” indeed: (i) synthesizes neuropeptides, neurotrophic factors, neurotrans-
mitters, hypothalamic hormones/releasing factors and their receptors, (ii) like brain 
expresses endocannabinoids and amyloid precursor protein and, for steroidogenesis, 
the enzyme aromatase (P450arom), (iii) adipocytes may originate from the neural crest 
cells, and (iv) adipose-derived stem cells  may differentiate into neuronal cells. Further 
molecular profiling of adipose tissue may provide new biological insights on its neu-
roendocrine potential. Overall this may frame a novel field of study, neuroadipobiol-
ogy; its development and clinical application may contribute to the improvement of 
human’s health.  
Adipobiology 2009; 1:87-93
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e�do� a�d para�r��e �ay ��t� ma�y or�a�s �� t�e �ody (F��. 
1). �� effe�t, �ra���ad�pose �et�ork plays a p�votal role �� t�e 
re��lat�o� of food ��take a�d e�er�y �ala��e (2) as �ell as �y�
pot�alam���p�t��tary �ells prod��e “ad�potrop���s” (see �elo�). 
�t �s ���reas���ly re�o���zed t�at ad�pose t�ss�e expresses �ot 
o�ly meta�ol��, ��t also se�retory p�e�otype, sy�t�es�z��� a�d 
releas��� more t�a� 100 s���al��� prote��s des���ated ad�pok�
��es (2�5). These are �mpl��ated �� t�e re��lat�o� of e�er�y, l�p�d 
a�d �l��ose �omeostas�s, ��flammat�o�, �mm���ty a�d vas��lar 
to�e as �ell as t�e pat�o�e�es�s of  �ard�ometa�ol�� a�d �e�ro�
de�e�erat�ve d�seases. 
Neuroendocrinology of adipose tissue 
W��le ��mero�s st�d�es �ave demo�strated t�at �ra�� �a� �o��
trol ad�pose t�ss�e f���t�o�s, �t �s o�ly �o� �e�om��� appare�t 
t�at t�e �o�trol �s ��d�re�t�o�al, t�at �s, t�e ad�pose t�ss�e �a� 
�o�trol �ra�� �e�roe�do�r��e f���t�o�s. For ��sta��e, (i) ma�y 
�e�ropept�des a�d �e�rotrop��� fa�tors a�d t�e�r re�eptors are 
s�ared �y t�e ad�pose t�ss�e a�d �ra�� (2�9), (ii) t�e ad�pok��es 
lept��, ad�po�e�t��, res�st�� a�d fast������d��ed ad�pose fa�tor 
(a���opo�et���l�ke prote�� 4) a�d t�e�r re�eptors are expressed 
�� t�e �ra�� (10�15), (iii) a s��set of ad�po�ytes may or����ate 
from t�e �e�ral �rest �ells (16), a�d (iv) �� �o��lt�res of 3T3�
L1 ad�po�ytes ��t� �e�ro�s, ad�po�yte�der�ved apol�poprote��s 
e��a��e �e�r�to�e�es�s a�d sy�apto�e�es�s (17). 
 Vice versa, ad�pose t�ss�e prod��es (i) �e�ropept�de tyro�
s��e (�PY), s��sta��e P, �al��to��� �e�e�related prote�� a�d 
ot�er �e�ropept�des (18�25), a�d (ii) �l�tamate a�d �amma�
am��o��tyr�� a��d (�ABA) �e�rotra�sm�tters, ��met�yl�D�as�
partate (�MDA) a�d �ABA re�eptors, a�d ves���lar �l�tamate 
tra�sporters (26,27). Moreover, ma�rop�a�es, mast �ells a�d 
ot�er �mm��e �ells asso��ate ��t� �ot� ad�pose t�ss�e (3) a�d 
p�t��tary �la�d (28).
 F�rt�er, most p�t��tary �ormo�es a�d �ypot�alam�� releas�
��� fa�tors, termed “ad�potrop���s” (29), express t�e�r re�eptors 
�� ad�pose t�ss�e, �reat��� �ypot�alam���p�t��tary�ad�pose ax�s 
(29,30) as �ell as some �ypot�alam�� releas��� fa�tors are pro�
d��ed �y ad�pose t�ss�e (31,32); re�e�tly, p��eal�ad�pose �et�ork 
�s also appre��ated (see Ra�ĉ�ć et al’ s a�stra�t �� t��s vol�me 
of Adipobiology). Also, var�o�s �e�rotrop��� fa�tors ���l�d��� 
�erve �ro�t� fa�tor (��F), �ra���der�ved �e�rotrop��� fa�tor 
(BD�F), ��l�ary �e�rotrop��� fa�tor (C�TF), vas��lar e�dot�e�
l�al �ro�t� fa�tor, ��s�l���l�ke �ro�t� fa�tor, a�d a���opo�et�� 
are sy�t�es�zed a�d released from ad�pose t�ss�e (20,25,33�37). 
 W��le ��F �as first d�s�overed �y R�ta Lev��Mo�tal���� �� 
1951 as �erve �ro�t� st�m�lat��� prote�� prod��ed �� lar�est 
amo��t �y t�e mo�se s��ma�d���lar �la�ds (38), �t appears to�
day t�at t�e ad�pose t�ss�e may also �e a ma�or ��olo���al so�r�e 










Figure 1.  A drawing illustrating both secretory and receptive nature of adipose tissue (AT). At secretory level, AT-derived sig-
naling molecules communicate via   multiple pathways such as endocrine (arrows 1,4,5, from up-down), paracrine (arrow 2) 
and autocrine (arrow 3, curved) as well as via exosomes (multivesicular body-derived microvessels) and ectosomes (plasma 
membrane-shedding microparticles) (see references 5,89; for exosomes/adiposomes, see 90). At receptive level, AT possesses 
receptors for various ligands. Modified from 63.
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�ote�ort�y, semap�or�� (Sema3A) a�d �ts re�eptor �e�rop��
l���1 (41), a�d pa�top�ys��, a prote�� related to t�e �e�roe�do�
�r��e�spe��fi� sy�aptop�ys�� (42), are expressed �� ad�pose t�s�
s�e as �ell as �e�ral a�d �l�al markers �� �e�rally d�ffere�t�ated 
ad�pose�der�ved stromal �ells (43�45).
 A�ot�er �e�roe�do�r��e feat�re of ad�pose t�ss�e m���t �e �ts 
o�� prod��t�o� of �ot� stero�ds a�d e�do�a��a���o�ds. There 
�s at prese�t �lear ev�de��e t�at ad�pose t�ss�e, l�ke �ra�� a�d �ts 
aromatase (P450arom) a�d �e�rostero�ds, prod��es ad�poster�
o�ds (see 3,46; t�e term “ad�postero�ds” �as �ee� ��trod��ed �y 
Mas�zak� � et al �� 2004). ��do�a��a���o�ds a�d t�e�r re�ep�
tors, re�e�tly exte�s�vely st�d�ed �� food ��take �o�trol a�d re�
�ard p�e�ome�a, are expressed �� �ot� �ypot�alam�s/p�t��tary 
�la�d a�d ad�pose t�ss�e (47). 
 Last ��t �ot least, �t �as �ee� re�e�tly d�s�losed a meta�ol�� 
parad��m for Alz�e�mer’s d�sease pat�o�e�es�s ���l�d��� t�e 
role of o�es�ty, ��olesterol a�d ad�pok��es �� �e�rode�e�erat�o� 
(48�50). Also, �t �s ���reas���ly �lear t�at t�e �ypot�alam�s �s 
�ot t�e o�ly s�te of lept�� a�t�o�, �or food ��take �s t�e o�ly ��o�
lo���al effe�t of lept��. Rat�er, lept�� �s a ple�otrop�� ad�pok��e 
t�at s�pports lear���� a�d memory a�d �as �e�rotrop��� a�t�v�
�ty (14,15,51�53; also Ar�e� �ertler �� t��s vol�me of Adipobiol-
ogy; for apel��, a �e� ad�pok��e, see 54,55). �t�er �e�rotrop��� 
fa�tors prod��ed �y ad�pose t�ss�e (20,25,33�37,39,40) may also 
�o�tr���te to �e�roprote�t�o� �� var�o�s �e�ropsy���atr�� d�s�
eases (rev�e�ed �� 56).
From enterochromaffin cells to adipose tissue
��stor��ally, ��kola� Ko�sta�t��ov��� K�l���tsky (1856�1925) 
�as �de�t�fied t�e e�tero��romaffi� �ells fo��d �� t�e �rypts of 
L�e�erk��� of �astro��te�st��al m��osa, �� 1897. Th�s d�s�overy 
formed t�e �as�s for t�e s��seq�e�t del��eat�o� of t�e d�ff�se 
�e�roe�do�r��e system (D��S) �y Fr�edr��� Feyrter �� 1938 
(rev�e�ed �� 57,58); examples of D��S ���l�de Feyrter’s �elle� 
Zelle� (�lear �ells) �� pa��reas a�d ��t, test���lar Leyd�� �ells 
(59), �epat�� stellate �ells (�to �ells) (60) a�d ot�er �ells d�ssem��
�ated t�ro���o�t t�e �ody.. 
 Dancing around t�e a���m�lat��� ev�de��e of sy�t�es�s a�d 
release of m�lt�ple �e�ro�al a�d �e�roe�dro�r��e fa�tors a�d 
express�o� of t�e�r re�eptors a�d var�o�s �e�ral markers (Ta�le 
1�3), �e propose t�at ad�pose t�ss�e m���t �e a �e� mem�er of 
D��S.
 Today (dnes, �� B�l�ar�a�, Ser��a�, Pol�s� a�d Slovak), ad��
pose t�ss�e �s “�ett��� �ervo�s” ��deed (61). Metap�or��ally, t��s 
tale�ted t�ss�e �s ���reas��� dramat��ally �ts ��tell��e��e q�o�
t�e�t (�Q) (62). As �ell as t�e ��t �s �o�s�dered a se�o�d �ra�� 
(58), t�e ad�pose t�ss�e may l�kely f���t�o� as a t��rd �ra�� (63). 
Alt�o��� “a�se��e of proofs �s �ot proof of a�se��e”, f�rt�er 
�e�roe�do�r��e profil��� of ad�pose t�ss�e �s req��red. �t may 
prov�de �e� ��olo���al ��s���ts o� some “�e��omers” s��� as 
��F, BD�F, C�TF, ��tr�� ox�de (64, also T��çel et al �� t��s vol�
Table 1. 
Neuronal and neuroendocrine factors in adipose tissue
Neuropeptides
Agouti protein (2-5)*
Neuropeptide tyrosine (NPY) (20,25)
Calcitonin gene-related peptide (18)
Adrenomedullin (18)
Somatostatin (19)






Corticotropin-releasing hormone (CRH) (32)
Stresscopin and urocortin (CRH-like peptides) (32)
Apelin (54; cf. 55)
Nesfatin-1 (67)
Neurotrophic factors
Leptin (2-5; cf. 15,51-53)
Apolipoprotein D, E3 (17)
Nerve growth factor (20,25,33,36)
Brain-derived neurotrophic factor (34,35,88)
Angiopoietin-1 (37)
Vascular endothelial growth factor (39)
Ciliary neurotrophic factor (20,39)
Glial cell line-derived neurotrophic factor (39,88)
Steroids (3,46; cf.81-83)




Gamma-aminobutyric acid (GABA) (26)
* References are indicated in parentheses.
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�me of Adipobiology), metallot��o�e��s (65, �f. 66), �e�ropep�
t�des B a�d W a�d �esfat���1 (67), a�d t�e a�t��a���� prote�� 
klot�o (68). ���ards, t��s may ope� a �ovel field of resear��, 
�e�road�po��olo�y. Systems ��olo�y approa�� ��te�rat��� �e��
roe�do�r��olo�y, �e�ro�mm��olo�y a�d �e�road�po��olo�y 
may ��deed �o�tr���te to t�e �mproveme�t of ��ma�’s �ealt� 
a�d lo��ev�ty.
Conclusion
�� 1999 Al�ee Mess��� p��l�s�ed �� Hepatology (vol�me 29, 
pp 602�603) �d�tor�al e�t�tled “�est�� �� t�e L�ver – Lesso�s 
from t�e Bra��”. �e �rote: “Most �e�ros��e�t�sts ma�a�e to �et 
t�ro��� ea�� day ��t�o�t t���k��� of t�e l�ver eve� o��e… ��t 
� t���k t�at �s a�o�t to ��a��e.” Th�s may also �e t�e �ase for 
ad�pose t�ss�e.
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